← Eichor
Study identifier: NCT07065669 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation

Condition: Obsessive-Compulsive Disorder  ·  Sponsor: University of California, San Francisco

PhaseNA
Planned participants30
Who can joinAll sexes, 13 Years to 17 Years
Healthy volunteersNo

About this study

This is a pilot study to examine the tolerability, safety and early efficacy of two forms of transcranial magnetic stimulation (TMS) for treating adolescents with Obsessive Compulsive Disorder (OCD) who have experienced limited improvements with usual treatments for OCD in adolescents. The project's primary goal is to examine whether adolescents can complete 3 consecutive weeks of TMS administered 5 days per week, and to describe the type of and how common individual side effects with TMS occur in adolescents with OCD. Participants will: * visit the clinic every weekday for 3 weeks (15 days) to receive TMS treatments * have a brain MRI scan before TMS treatments begins and after finishing all TMS * complete questionnaires and report changes in behavior and physical symptoms

This description comes directly from the study's public registry record.

Talk to the study team

Starlette Khim, BA  ·  415-514-5743  ·  ocdteenTMS@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California, San FranciscoSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07065669